Unilife Corporation (UNIS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Unilife Corporation (UNIS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011973
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems with focus on wearable injector products. It develops, manufactures and distributes safety engineered syringes for medical device and pharmaceutical industries. The company’s product portfolio includes wearable injectors, prefilled syringes, insulin delivery systems, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems and novel devices for targeted organ delivery. The company supplies its products to pharmaceutical and biotechnology companies that develops injectable therapies to treat acute and chronic diseases. It has manufacturing facility in York, Pennsylvania. The company operates in North America and Australia. Unilife is headquartered in Pennsylvania, the US.

Unilife Corporation (UNIS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Unilife Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Unilife Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Unilife Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Unilife Corporation, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Unilife Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Unilife Corporation, Medical Equipment, Deal Details 11
Venture Financing 11
Unilife Raises USD5 Million in Venture Financing 11
Unilife Raises USD10.6 Million in Financing Round 12
Partnerships 13
Unilife Enters Into Agreement With Pharma Company For Ocu-Ject 13
Unilife Enters Into Co-Development Agreement With A Pharma Company 14
Amgen Enters into Licensing Agreement with Unilife 15
Equity Offering 16
Unilife to Raise USD45 Million in Private Placement of Shares 16
Unilife Raises USD47.4 Million in Public Offering of Shares 17
Unilife to Raise Funds through Private Placement of Shares 19
Unilife Raises Funds through Private Placement of Shares 20
Unilife Completes Public Offering Of Shares For US$6.4 Million 21
Unilife Completes Private Placement Of Shares For US$0.5 Million 22
Unilife Completes Public Offering Of Shares For US$4.2 Million 23
Unilife Completes Private Placement Of Shares For US$6.3 Million 24
Unilife Completes Private Placement Of Shares For US$4.6 Million 25
Unilife Completes Private Placement Of Units For US$10 Million 26
Unilife Completes Public Offering Of Shares For US$4 Million 28
Unilife Completes Public Offering Of Common Stock For US$20 Million 29
Unilife Completes Public Offering Of Common Stock For US$35.9 Million 30
Debt Offering 32
Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 32
Unilife Raises USD10 Million in Second Tranche of Private Placement of Debt Securities Due 2020 34
Unilife Corporation – Key Competitors 35
Unilife Corporation – Key Employees 36
Unilife Corporation – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
Nov 02, 2016: Unilife Provides Business Update 38
Oct 24, 2016: Unilife Announces Fiscal Year 2016 Finanicial Results 39
Feb 09, 2016: Unilife Announces Financial Results For the Second Quarter of Fiscal Year 2016 41
Corporate Communications 42
Oct 31, 2016: Unilife Appoints Rosemary Crane and Duane DeSisto to its Board of Directors 42
Legal and Regulatory 43
Apr 12, 2017: Unilife Files for Chapter 11 Protection 43
Sep 29, 2016: Unilife Provides Trading Update 44
Sep 23, 2016: Unilife Corporation Announces Receipt of Delinquency Letter from NASDAQ Relating to Fiscal 2016 Form 10-K 45
Jul 18, 2016: Unilife Submits Plan to Regain Compliance with NASDAQ Requirements 46
May 23, 2016: Unilife Announces Receipt of Deficiency Letter from NASDAQ 47
Other Significant Developments 48
Oct 24, 2016: Unilife Announces Filing of 2016 10-K 48
Jul 28, 2016: Unilife Announces New Leadership Team and Targeted Growth Strategy 50
Mar 14, 2016: Unilife Realigns Business Units and Leadership Team 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Unilife Corporation, Medical Equipment, Key Facts, 2016 2
Unilife Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Unilife Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Unilife Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Unilife Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Unilife Corporation, Deals By Market, 2011 to YTD 2017 9
Unilife Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Unilife Raises USD5 Million in Venture Financing 11
Unilife Raises USD10.6 Million in Financing Round 12
Unilife Enters Into Agreement With Pharma Company For Ocu-Ject 13
Unilife Enters Into Co-Development Agreement With A Pharma Company 14
Amgen Enters into Licensing Agreement with Unilife 15
Unilife to Raise USD45 Million in Private Placement of Shares 16
Unilife Raises USD47.4 Million in Public Offering of Shares 17
Unilife to Raise Funds through Private Placement of Shares 19
Unilife Raises Funds through Private Placement of Shares 20
Unilife Completes Public Offering Of Shares For US$6.4 Million 21
Unilife Completes Private Placement Of Shares For US$0.5 Million 22
Unilife Completes Public Offering Of Shares For US$4.2 Million 23
Unilife Completes Private Placement Of Shares For US$6.3 Million 24
Unilife Completes Private Placement Of Shares For US$4.6 Million 25
Unilife Completes Private Placement Of Units For US$10 Million 26
Unilife Completes Public Offering Of Shares For US$4 Million 28
Unilife Completes Public Offering Of Common Stock For US$20 Million 29
Unilife Completes Public Offering Of Common Stock For US$35.9 Million 30
Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 32
Unilife Raises USD10 Million in Second Tranche of Private Placement of Debt Securities Due 2020 34
Unilife Corporation, Key Competitors 35
Unilife Corporation, Key Employees 36
Unilife Corporation, Other Locations 37
Unilife Corporation, Subsidiaries 37

★海外企業調査レポート[Unilife Corporation (UNIS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • T&D Holdings, Inc.:企業の戦略・SWOT・財務分析
    T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Xtant Medical Holdings Inc (XTNT)-医療機器分野:企業M&A・提携分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteow …
  • Surgical Care Affiliates LLC (SCAI)-医療機器分野:企業M&A・提携分析
    Summary Surgical Care Affiliates LLC (SCA) is a healthcare organization that offers patient care services. The organization's services include physician governance and engagement, scheduling optimization, staffing optimization, supply chain optimization, and case costing and profitability analysis. …
  • ContraVir Pharmaceuticals Inc (CTRV):企業の財務・戦略的SWOT分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Peregrine Holdings Ltd:企業の戦略・SWOT・財務分析
    Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Rallis India Ltd (RALLIS):企業の財務・戦略的SWOT分析
    Summary Rallis India Ltd (Rallis), a subsidiary of Tata Chemicals Ltd, is an agri-solutions service provider. The company’s business portfolio includes domestic crop protection, international business, contract manufacturing, seeds, plant growth nutrients and agri services. Its products portfolio in …
  • Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析
    Summary Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene …
  • Magnitogorsk Iron & Steel Works:企業の戦略・SWOT・財務情報
    Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report Summary Magnitogorsk Iron & Steel Works - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ascendance Biotechnology Inc-医療機器分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Bc Hydro:企業の戦略・SWOT・財務分析
    Bc Hydro - Strategy, SWOT and Corporate Finance Report Summary Bc Hydro - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Rehrig Pacific Company:企業の戦略的SWOT分析
    Rehrig Pacific Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Toyo Tire & Rubber Co Ltd (5105):企業の財務・戦略的SWOT分析
    Toyo Tire & Rubber Co Ltd (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Merial Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Merial Ltd (Merial), a subsidiary of Boehringer Ingelheim GmbH, is an animal healthcare center that produces and markets pharmaceutical products and vaccines. The center offers products for dogs, cats, beef, dairy, equine, and swine to improve their health and performance. It develops specif …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BHP:企業のM&A・事業提携・投資動向
    BHP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BHP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, …
  • ExxonMobil Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ExxonMobil Pipeline Co (EMPCO) a subsidiary of Exxon Mobil Corporation is an oil and gas company that offers petroleum products transportation solutions. The company transports crude oil, refined products, liquefied petroleum gases, natural gas liquids and chemical feed-stocks. Its distribut …
  • Ariste Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Ariste Medical LLC (Ariste) is a medical device company that develops drug eluting surgical implants. The company develops drug eluting tunneled dialysis catheter for hemodialysis, drug eluting mesh for hernia repair, and drug eluting vascular graft for peripheral bypass. It also develops dr …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers. The company develops first-in-class products utilizing its proprietary technology NanoXray, based on the physical mode of action of nanoparticles that increase the X-rays do …
  • Corning Incorporated (GLW)-医療機器分野:企業M&A・提携分析
    Summary Corning Incorporated (Corning) manufactures and sells ceramics, specialty glasses and related materials. The company’s product portfolio includes glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for tele …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆